Main Page
From Pubdrug
Welcome to PubDrug - The open access drug resource
We currently have a total of 17 fully-certified drug records. For information about PubDrug and our continuing development, please consult our Planning document.
Expanded Drug Monographs List, Current to August 2008
Our certified monographs include:
- Acyclovir
- Alendronate
- Amlodipine
- Atorvastatin
- Cholecalciferol
- Donepezil
- Duloxetine
- Escitalopram
- Esomeprazole
- Memantine
- Montelukast
- Pregabalin
- Sertraline
- Sildenafil
- Tadalafil
- Tramadol
- Valacyclovir
All italicized drug monographs have been added since our last update. All drug monographs in bold have been converted to the new PubDrug template.
This progress would not have been possible without the amazing efforts of a handful of fourth-year professional Pharm.D. students at the University at Buffalo. Their user pages are linked from the above records and we encourage everyone to visit them.
There are other types of PubDrug records being developed. More information will be posted here as this work progresses.
For information on drugs not listed above, please visit the National Library of Medicine Drug Information Portal.
Comments about PubDrug
PubDrug was founded November 8, 2006, in an effort to develop a copyright-free, royalty-free, full-text drug resource. PubDrug's intended audience includes all health practitioners, researchers, informaticians, and the general public.
PubDrug is being developed as a wiki, allowing us to harness the expertise of the entire internet to help create this database. However, it is our intention to also apply editorial guidelines and fact-checking to help keep this data as error-free as possible.
We would like to invite you to assist us in this effort. More information will be posted here as this project continues to take shape. You may also wish to look at the proposal and our Planning document.
E-mail sbrower@buffalo.edu if you have any questions about this project and/or would like to volunteer. Visit the Pubdrug:Community_Portal for interactive discussion of the project. Watch this space for future announcements!
Note: The URL www.pubdrug.org redirects to this page currently, but is being tweaked. You may wish to bookmark the URL for this page for the time being while we work out the kinks with the redirect.
